Abstract
Failure of Preventive Treatments in Migraine: An Observational Retrospective Study in a Tertiary Headache Center
Highlights
Despite the criteria of acute migraine treatment and prevention have been well described, there are still unmet needs, for a general underuse and low benefit of preventive treatments.The aim of the present study was to observe retrospectively the short term effect of preventive treatment in a cohort of migraine patients come at a tertiary headache center, using data from an electronic medical record
The rate of improvement was estimated on the triptans use reduction, and was even significantly lower among subjects treated with oral preventive therapies in comparison with those without these drugs, though a mild improvement was present in the group with chronic migraine [3]
General considerations on headache populations These real life data showed that in our south Italy tertiary headache center, the most of patients suffered from medium-high frequency migraine, not previously treated with preventive drugs, and only a minority of them used triptans
Summary
Despite the criteria of acute migraine treatment and prevention have been well described , there are still unmet needs, for a general underuse and low benefit of preventive treatments.The aim of the present study was to observe retrospectively the short term effect of preventive treatment in a cohort of migraine patients come at a tertiary headache center, using data from an electronic medical record. Despite the criteria of acute migraine treatment and prevention have been well described , there are still unmet needs, for a general underuse and low benefit of preventive treatments. Despite the criteria of acute episodes treatment and prevention have been well described [2], there are still a large proportion of patients with unmet needs, for a general underuse and low benefit of preventive treatments [3]. The French SMILE study, assessed the determinants of prescription of migraine preventive therapy among GPs and neurologists and factors determining eligibility, as frequency and severity of headache and scarce efficacy of acute treatment [5]. The study just underlined that the current use of preventive therapies is scarce and with negligible benefits, and that the most of migraine patients have currently unmet needs
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
